Skip to main content

NUEVOS METODOS PARA LA EFICIENCIA Y SEGURIDAD DEL PANCREAS ARTIFICIAL DOMICILIARIO EN DIABETES TIPO 1

DPI2013-46982-C2-1-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2013
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target

  • Rossetti, P.
  • Quirós, C.
  • Moscardo-Garcia, Vanessa
  • Comas, A.
  • Giménez, M.
  • Ampudia-Blasco, F.J.
  • León, F.
  • Montaser Roushdi Ali, Eslam
  • Conget, I.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Postprandial (PP) control remains a challenge for closed-loop (CL) systems. Few studies with inconsistent results have systematically investigated the PP period. Objective: To compare a new CL algorithm with current pump therapy (open loop [OL]) in the PP glucose control in type 1 diabetes (T1D) subjects. Methods: A crossover randomized study was performed in two centers. Twenty T1D subjects (F/M 13/7, age 40.7 -10.4 years, disease duration 22.6 +/- 9.9 years, and A1c 7.8% +/- 0.7%) underwent an 8-h mixed meal test on four occasions. In two (CL1/CL2), after meal announcement, a bolus was given followed by an algorithmdriven basal infusion based on continuous glucose monitoring (CGM). Alternatively, in OL1/OL2 conventional pump therapy was used. Main outcome measures were as follows: glucose variability, estimated with the coefficient of variation (CV) of the area under the curve (AUC) of plasma glucose (PG) and CGM values, and from the analysis of the glucose time series; mean, maximum (C-max), and time to C-max glucose concentrations and time in range (<70, 70-180, >180 mg/dL). Results: CVs of the glucose AUCs were low and similar in all studies (around 10%). However, CL achieved greater reproducibility and better PG control in the PP period: CL1 = CL2<OL1<OL2 (PG(mean) 123 +/- 47 and 125 +/- 44 vs. 152 +/- 53 and 159 +/- 54 mg/dL) and C-max OL 217.1 +/- 67.0 mg/dL versus CL 183.3 +/- 63.9 mg/dL, P < 0.0001. Time-in-range was higher with CL versus OL (80% vs. 64%; P < 0.001). Neither the time below 70 mg/dL (CL 6.1% vs. OL 3.2%; P > 0.05) nor the need for oral glucose was significantly different (CL 40.0% vs. OL 22.5% of meals; P = 0.054). Conclusions: This novel CL algorithm effectively and consistently controls PP glucose excursions without increasing hypoglycemia. Study registered at ClinicalTrials.gov: study number NCT02100488., This work was supported by the Spanish Ministry of Economy and Competitiveness through Grants DPI2013-46982-C2-1-R and DPI2013-46982-C2-2-R, and the EU through FEDER funds. C.Q. is the recipient of a grant from the Hospital Clinic i Universitari of Barcelona ("Ajut a la recerca Josep Font 2014-2017").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Real-time estimation of plasma insulin concentration from continuous glucose monitor measurements

  • de Pereda Sebastián, Diego
  • Rossetti, Paolo
  • Ampudia Blasco, Francisco Javier
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Bondía Company, Jorge|||0000-0001-7286-3719
Continuous glucose monitors can measure interstitial glucose concentration in real time for closed-loop glucose control systems, known as artificial pancreas. These control systems use an insulin feedback to maintain plasma glucose concentration within a narrow and safe range, and thus to avoid health complications. As it is not possible to measure plasma insulin concentration in real time, insulin models have been used in literature to estimate them. Nevertheless, the significant interand intra-patient variability of insulin absorption jeopardizes the accuracy of these estimations. In order to reduce these limitations, our objective is to perform a real-time estimation of plasma insulin concentration from continuous glucose monitoring (CGM). Hovorka s glucose insulin model has been incorporated in an extended Kalman filter in which different selected time-variant model parameters have been considered as extended states. The observability of the original Hovorka s model and of several extended models has been evaluated by their Lie derivatives. We have evaluated this methodology with an in-silico study with 100 patients with Type 1 diabetes during 25 h. Furthermore, it has been also validated using clinical data from 12 insulin pump patients with Type 1 diabetes who underwent four mixed meal studies. Real-time insulin estimations have been compared to plasma insulin measurements to assess performance showing the validity of the methodology here used in comparison with that formerly used for insulin models. Hence, real-time estimations for plasma insulin concentration based on subcutaneous glucose monitoring can be beneficial for increasing the efficiency of control algorithms for the artificial pancreas., This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion through Grant DPI-2010-20764-C02-01 and Grant DPI-2013-46982-C2-1-R, and the European Union through FEDER fund.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Extensive assessment of blood glucose monitoring during postprandial period and its impact on closed-loop performance

  • Biagi, L.
  • Hirata-Bertachi, A.
  • Conget, I.
  • Quirós, C.
  • Giménez, M.
  • Ampudia-Blasco, F.J.
  • Rossetti, P.
  • Vehí, J.
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Closed-loop (CL) systems aims to outperform usual treatments in blood glucose control and continuous glucose monitors (CGM) are a key component in such systems. Meals represents one of the main disturbances in blood glucose control, and postprandial period (PP) is a challenging situation for both CL system and CGM accuracy. Methods: We performed an extensive analysis of sensor¿s performance by numerical accuracy and precision during PP, as well as its influence in blood glucose control under CL therapy. Results: During PP the mean absolute relative difference (MARD) for both sensors presented lower accuracy in the hypoglycemic range (19.4 ± 12.8%) than in other ranges (12.2 ± 8.6% in euglycemic range and 9.3 ± 9.3% in hyperglycemic range). The overall MARD was 12.1 ± 8.2%. We have also observed lower MARD for rates of change between 0 and 2 mg/dl. In CL therapy, the 10 trials with the best sensor spent less time in hypoglycemia (PG < 70 mg/dl) than the 10 trials with the worst sensors (2 ± 7 minutes vs 32 ± 38 minutes, respectively). Conclusions: In terms of accuracy, our results resemble to previously reported. Furthermore, our results showed that sensors with the lowest MARD spent less time in hypoglycemic range, indicating that the performance of CL algorithm to control PP was related to sensor accuracy., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project has been partially supported by the Spanish Government through Grants DPI 2013-46982-C2-1-R, DPI 2016-78831-C2-1-R, DPI 2013-46982-C2-2-R, and DPI 2016-78831-C2-2-R, the National Council of Technological and Scientific Development, CNPq Brazil through Grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Accuracy of Continuous Glucose Monitoring before, during, and after Aerobic and Anaerobic Exercise in Patients with Type 1 Diabetes Mellitus

  • Biagi, L.
  • Bertachi, A.
  • Quirós, C.
  • Giménez, M.
  • Conget, I.
  • Vehí, Josep
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Continuous glucose monitoring (CGM) plays an important role in treatment decisions for patients with type 1 diabetes under conventional or closed-loop therapy. Physical activity represents a great challenge for diabetes management as well as for CGM systems. In this work, the accuracy of CGM in the context of exercise is addressed. Six adults performed aerobic and anaerobic exercise sessions and used two Medtronic Paradigm Enlite-2 sensors under closed-loop therapy. CGM readings were compared with plasma glucose during different periods: one hour before exercise, during exercise, and four hours after the end of exercise. In aerobic sessions, the median absolute relative difference (MARD) increased from 9.5% before the beginning of exercise to 16.5% during exercise (p < 0.001), and then decreased to 9.3% in the first hour after the end of exercise (p < 0.001). For the anaerobic sessions, the MARD before exercise was 15.5% and increased without statistical significance to 16.8% during exercise realisation (p = 0.993), and then decreased to 12.7% in the first hour after the cessation of anaerobic activities (p = 0.095). Results indicate that CGM might present lower accuracy during aerobic exercise, but return to regular operation a few hours after exercise cessation. No significant impact for anaerobic exercise was found., This project was partially supported by the Spanish Government through grants DPI2013-46982-C2-1-R, DPI2013-46982-C2-2-R, DPI2016-78831-C2-1-R, and DPI2016-78831-C2-2-R, and by the National Council of Technological and Scientific Development, CNPq Brazil through grants 202050/2015-7 and 207688/2014-1.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

An algebraic approach to the structural properties of positive state control systems

  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Romero Vivó, Sergio|||0000-0001-6689-4324
[EN] In this paper, we deal with discrete-time linear control systems in which the state is constrained to lie in the positive orthant R_+^n independently of the inputs involved, that is, the inputs can take negative values. Such (positive state) systems appear, for example, in ecology models where the removal of individuals from a population is described. Controllability and reachability are fundamental properties of a system that show its ability to move in space, which are analyzed from an algebraic point of view throughout the text, paying special attention to the single-input case., This work has been partially supported by Ministerio de Ciencia e Innovacion through Grants DPI-2013-46982-C2-1-R and MTM-2013-43678-P.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Insulin Estimation and Prediction A REVIEW OF THE ESTIMATION AND PREDICTION OF SUBCUTANEOUS INSULIN PHARMACOKINETICS IN CLOSED-LOOP GLUCOSE CONTROL

  • Bondía Company, Jorge|||0000-0001-7286-3719
  • Romero Vivó, Sergio|||0000-0001-6689-4324
  • Ricarte Benedito, Beatriz|||0000-0001-8094-1908
  • Diez, José-Luís|||0000-0002-5659-1212
This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) through grant DPI2013-46982-C2-1-R and the EU through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Stochastic Seasonal Models for Glucose Prediction in the Artificial Pancreas

  • Montaser Roushdi Ali, Eslam
  • Diez, José-Luís|||0000-0002-5659-1212
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Linear empirical dynamic models have been widely used for glucose prediction. The extension of the concept of seasonality, characteristic of other domains, is explored here for the improvement of prediction accuracy. Methods: Twenty time series of 8-hour postprandial periods (PP) for a same 60g-carbohydrate meal were collected from a closed-loop controller validation study. A single concatenated time series was produced representing a collection of data from similar scenarios, resulting in seasonality. Variability in the resulting time series was representative of worstcase intrasubject variability. Following a leave-one-out cross-validation, seasonal and nonseasonal autoregressive integrated moving average models (SARIMA and ARIMA) were built to analyze the effect of seasonality in the model prediction accuracy. Further improvement achieved from the inclusion of insulin infusion rate as exogenous variable was also analyzed. Prediction horizons (PHs) from 30 to 300 min were considered. Results: SARIMA outperformed ARIMA revealing a significant role of seasonality. For a 5-h PH, average MAPE was reduced in 26.62%. Considering individual runs, the improvement ranged from 6.3% to 54.52%. In the best-performing case this reduction amounted to 29.45%. The benefit of seasonality was consistent among different PHs, although lower PHs benefited more, with MAPE reduction over 50% for PHs of 60 and 120 minutes, and over 40% for 180 min. Consideration of insulin infusion rate into the seasonal model further improved performance, with a 61.89% reduction in MAPE for 30-min PH and reductions over 20% for PHs over 180 min. Conclusions: Seasonality improved model accuracy allowing for the extension of the PH significantly., The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the Spanish Ministry of Economy and Competitiveness, grants DPI2013-46982-C2-1-R and DPI2016-78831-C2-1-R, and the European Union through FEDER funds.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration

  • Moscardo-Garcia, Vanessa
  • Ampudia-Blasco, Francisco Javier
  • Fanelli, Carmine G
  • Lucidi, Paola
  • Rossetti, Paolo
  • Bondía Company, Jorge|||0000-0001-7286-3719
[EN] Background: Continuous glucose monitoring (CGM) accuracy during hypoglycemia is suboptimal. This might be partly explained by insulin or hypoglycemia-induced changes in the plasma interstitial subcutaneous (SC) fluid glucose gradient. The aim of the present study was to assess the role of plasma insulin (PI) and hypoglycemia itself in the plasma and interstitial SC fluid glucose concentration in patients with type 1 diabetes mellitus. Methods: Eleven subjects with type 1 diabetes (age 36.59.1 years, HbA(1c) 7.90.4% [62.8 +/- 2.02mmol/mol]; mean +/- standard deviation) were evaluated under hyperinsulinemic euglycemia and hypoglycemia. Each subject underwent two randomized crossover clamps with either a primed 0.3 (low insulin) or 1mU/(kgmin) (high insulin) insulin infusion. The raw CGM signal was normalized with median preclamp values to obtain a standardized measure of the interstitial glucose (IG) concentration before statistical analysis. Results: The mean PI concentration was greater in high insulin studies (HISs) versus low insulin studies (LISs) (412.89 +/- 13.63 vs. 177.22 +/- 10.05pmol/L). During hypoglycemia, glucagon, adrenaline, free fatty acids, glycerol, and beta-OH-butyrate were higher in the LIS (P<0.0001). Likewise, the IG concentration was significantly different (P<0.0001). This was due to lower IG concentration than plasma glucose (PG) concentration during the euglycemic hyperinsulinemic phases in the HIS. In contrast, no difference was observed during hypoglycemia. This was the result of an unchanged PG/IG gradient during the entire LIS, while in the HIS, this gradient increased during the hyperinsulinemic euglycemia phase. Conclusion: Both PI levels and hypoglycemia affect the relationship between IG and PG concentration. ClinicalTrials.gov Identifier: NCT01714895., The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007/2013) under the grant agreement 252085 and FEDER funds, as well as the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants DPI2013-46982-C2-1-R and DPI2016-78831-C2-1-R.V.M. is recipient of an FPU grant ref FPU13/04253. We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study.